SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'CES'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GHM_A_CEDA1_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	ALA A 57 SER A 58 LYS A 61 SER A 118 ASN A 120 LYS A 222 GLY A 224	CES A 301 (-3.5A) CES A 301 (-1.3A) CES A 301 ( 4.1A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.2A)	0.37A	1ghmA-5zqeA: 21.4	1ghmA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GHM_A_CEDA1_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	SER A 58 LYS A 61 SER A 118 ASN A 120 LYS A 222 GLY A 224 ARG A 257	CES A 301 (-1.3A) CES A 301 ( 4.1A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.2A) CES A 301 (-2.9A)	0.79A	1ghmA-5zqeA: 21.4	1ghmA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_A_CFXA1300_1 (BETA-LACTAMASE)	5zqe	- (-)	8 / 12	ALA A 57 SER A 58 LYS A 61 SER A 118 ASN A 120 THR A 208 LYS A 222 GLY A 224	CES A 301 (-3.5A) CES A 301 (-1.3A) CES A 301 ( 4.1A) CES A 301 ( 3.7A) CES A 301 (-3.3A) CES A 301 (-4.3A) None CES A 301 (-3.2A)	0.44A	1i2wA-5zqeA: 22.4	1i2wA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_B_CFXB2300_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	ALA A 57 SER A 58 LYS A 61 SER A 118 ASN A 120 THR A 208 GLY A 224	CES A 301 (-3.5A) CES A 301 (-1.3A) CES A 301 ( 4.1A) CES A 301 ( 3.7A) CES A 301 (-3.3A) CES A 301 (-4.3A) CES A 301 (-3.2A)	0.48A	1i2wB-5zqeA: 22.3	1i2wB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_B_CFXB2300_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	SER A 58 LYS A 61 SER A 118 ASN A 120 THR A 208 GLY A 224 ARG A 257	CES A 301 (-1.3A) CES A 301 ( 4.1A) CES A 301 ( 3.7A) CES A 301 (-3.3A) CES A 301 (-4.3A) CES A 301 (-3.2A) CES A 301 (-2.9A)	0.86A	1i2wB-5zqeA: 22.3	1i2wB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_A_CFXA1001_1 (BETA-LACTAMASE CTX-M-9)	5zqe	- (-)	8 / 12	SER A 58 LYS A 61 SER A 118 ASN A 120 THR A 208 LYS A 222 GLY A 224 ASP A 227	CES A 301 (-1.3A) CES A 301 ( 4.1A) CES A 301 ( 3.7A) CES A 301 (-3.3A) CES A 301 (-4.3A) None CES A 301 (-3.2A) None	0.89A	1ymxA-5zqeA: 22.1	1ymxA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_B_CFXB1002_1 (BETA-LACTAMASE CTX-M-9)	5zqe	- (-)	7 / 12	SER A 58 LYS A 61 SER A 118 ASN A 120 LYS A 222 GLY A 224 ASP A 227	CES A 301 (-1.3A) CES A 301 ( 4.1A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.2A) None	0.81A	1ymxB-5zqeA: 22.2	1ymxB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_A_CE3A301_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5zqe	- (-)	6 / 12	LYS A 61 SER A 118 ASN A 120 THR A 208 LYS A 222 GLY A 224	CES A 301 ( 4.1A) CES A 301 ( 3.7A) CES A 301 (-3.3A) CES A 301 (-4.3A) None CES A 301 (-3.2A)	0.39A	3hlwA-5zqeA: 22.2	3hlwA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_B_CE3B302_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5zqe	- (-)	6 / 12	SER A 118 ASN A 120 THR A 208 LYS A 222 THR A 223 GLY A 224	CES A 301 ( 3.7A) CES A 301 (-3.3A) CES A 301 (-4.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A)	0.33A	3hlwB-5zqeA: 22.2	3hlwB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_A_PNNA300_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5zqe	- (-)	6 / 12	LYS A 61 ASN A 120 LYS A 222 THR A 223 GLY A 224 ASP A 227	CES A 301 ( 4.1A) CES A 301 (-3.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A) None	0.75A	3huoA-5zqeA: 22.1	3huoA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_B_PNNB301_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5zqe	- (-)	5 / 12	LYS A 61 ASN A 120 LYS A 222 GLY A 224 ASP A 227	CES A 301 ( 4.1A) CES A 301 (-3.3A) None CES A 301 (-3.2A) None	0.80A	3huoB-5zqeA: 22.2	3huoB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA)	5zqe	- (-)	9 / 12	ALA A 57 SER A 58 LYS A 61 ASN A 120 LEU A 160 THR A 223 GLY A 224 THR A 226 ARG A 257	CES A 301 (-3.5A) CES A 301 (-1.3A) CES A 301 ( 4.1A) CES A 301 (-3.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A) CES A 301 (-4.4A) CES A 301 (-2.9A)	0.63A	3mzeA-5zqeA: 33.7	3mzeA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NY4_A_SMXA308_1 (BETA-LACTAMASE)	5zqe	- (-)	8 / 12	SER A 58 SER A 118 THR A 208 ARG A 257 LYS A 222 THR A 223 GLY A 224 ASP A 227	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-4.3A) CES A 301 (-2.9A) None CES A 301 (-3.6A) CES A 301 (-3.2A) None	0.95A	3ny4A-5zqeA: 21.5	3ny4A-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_A_WPPA300_1 (BETA-LACTAMASE)	5zqe	- (-)	6 / 12	LYS A 61 SER A 118 ASN A 120 LYS A 222 GLY A 224 ASP A 227	CES A 301 ( 4.1A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.2A) None	0.68A	3q07A-5zqeA: 22.1	3q07A-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_B_WPPB400_1 (BETA-LACTAMASE)	5zqe	- (-)	6 / 12	LYS A 61 SER A 118 ASN A 120 LYS A 222 GLY A 224 ASP A 227	CES A 301 ( 4.1A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.2A) None	0.76A	3q07B-5zqeA: 9.9	3q07B-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_A_CEDA1_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	ALA A 57 SER A 58 SER A 118 ASN A 120 LYS A 222 THR A 223 GLY A 224	CES A 301 (-3.5A) CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A)	0.36A	3sh8A-5zqeA: 22.7	3sh8A-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_A_CEDA1_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	SER A 58 SER A 118 ASN A 120 LYS A 222 THR A 223 GLY A 224 ARG A 257	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A) CES A 301 (-2.9A)	0.85A	3sh8A-5zqeA: 22.7	3sh8A-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_B_CEDB1_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	ALA A 57 SER A 58 LYS A 61 ASN A 120 LYS A 222 GLY A 224 TYR A 231	CES A 301 (-3.5A) CES A 301 (-1.3A) CES A 301 ( 4.1A) CES A 301 (-3.3A) None CES A 301 (-3.2A) None	0.78A	3sh8B-5zqeA: 22.4	3sh8B-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_B_CEDB1_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	ALA A 57 SER A 58 LYS A 61 SER A 118 ASN A 120 LYS A 222 GLY A 224	CES A 301 (-3.5A) CES A 301 (-1.3A) CES A 301 ( 4.1A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.2A)	0.37A	3sh8B-5zqeA: 22.4	3sh8B-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_B_CEDB1_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	SER A 58 LYS A 61 ASN A 120 LYS A 222 GLY A 224 ARG A 257 TYR A 231	CES A 301 (-1.3A) CES A 301 ( 4.1A) CES A 301 (-3.3A) None CES A 301 (-3.2A) CES A 301 (-2.9A) None	1.02A	3sh8B-5zqeA: 22.4	3sh8B-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_B_CEDB1_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	SER A 58 LYS A 61 SER A 118 ASN A 120 LYS A 222 GLY A 224 ARG A 257	CES A 301 (-1.3A) CES A 301 ( 4.1A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.2A) CES A 301 (-2.9A)	0.82A	3sh8B-5zqeA: 22.4	3sh8B-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1)	5zqe	- (-)	7 / 12	LYS A 61 SER A 118 ASN A 120 THR A 208 LYS A 222 THR A 223 GLY A 224	CES A 301 ( 4.1A) CES A 301 ( 3.7A) CES A 301 (-3.3A) CES A 301 (-4.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A)	0.52A	4euzA-5zqeA: 22.1	4euzA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1)	5zqe	- (-)	7 / 12	SER A 118 ASN A 120 LEU A 160 THR A 208 LYS A 222 THR A 223 GLY A 224	CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-4.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A)	0.82A	4euzA-5zqeA: 22.1	4euzA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1)	5zqe	- (-)	5 / 10	SER A 118 ASN A 120 LYS A 222 THR A 223 GLY A 224	CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A)	0.58A	4fh2A-5zqeA: 22.5	4fh2A-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1)	5zqe	- (-)	5 / 10	SER A 118 ASN A 120 THR A 223 GLY A 224 ARG A 257	CES A 301 ( 3.7A) CES A 301 (-3.3A) CES A 301 (-3.6A) CES A 301 (-3.2A) CES A 301 (-2.9A)	1.14A	4fh2A-5zqeA: 22.5	4fh2A-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_A_CEDA301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	ALA A 57 SER A 58 SER A 118 ASN A 120 LYS A 222 THR A 223 GLY A 224	CES A 301 (-3.5A) CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A)	0.35A	4n9kA-5zqeA: 22.5	4n9kA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_A_CEDA301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	SER A 58 SER A 118 ASN A 120 LYS A 222 THR A 223 GLY A 224 ARG A 257	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A) CES A 301 (-2.9A)	0.82A	4n9kA-5zqeA: 22.5	4n9kA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_B_CEDB301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	ALA A 57 SER A 58 ASN A 120 LYS A 222 THR A 223 GLY A 224 TYR A 231	CES A 301 (-3.5A) CES A 301 (-1.3A) CES A 301 (-3.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A) None	0.72A	4n9kB-5zqeA: 22.6	4n9kB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_B_CEDB301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	ALA A 57 SER A 58 SER A 118 ASN A 120 LYS A 222 THR A 223 GLY A 224	CES A 301 (-3.5A) CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A)	0.32A	4n9kB-5zqeA: 22.6	4n9kB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_B_CEDB301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	SER A 58 ASN A 120 LYS A 222 THR A 223 GLY A 224 ARG A 257 TYR A 231	CES A 301 (-1.3A) CES A 301 (-3.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A) CES A 301 (-2.9A) None	1.00A	4n9kB-5zqeA: 22.6	4n9kB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_B_CEDB301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	SER A 58 SER A 118 ASN A 120 LYS A 222 THR A 223 GLY A 224 ARG A 257	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A) CES A 301 (-2.9A)	0.84A	4n9kB-5zqeA: 22.6	4n9kB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM5_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	5zqe	- (-)	5 / 12	ASN A 120 THR A 208 LYS A 222 THR A 223 GLY A 224	CES A 301 (-3.3A) CES A 301 (-4.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A)	0.27A	4pm5A-5zqeA: 22.1	4pm5A-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM7_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	5zqe	- (-)	5 / 12	LYS A 61 ASN A 120 THR A 208 LYS A 222 GLY A 224	CES A 301 ( 4.1A) CES A 301 (-3.3A) CES A 301 (-4.3A) None CES A 301 (-3.2A)	0.38A	4pm7A-5zqeA: 22.0	4pm7A-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM9_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	5zqe	- (-)	5 / 12	ASN A 120 THR A 208 LYS A 222 THR A 223 GLY A 224	CES A 301 (-3.3A) CES A 301 (-4.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A)	0.29A	4pm9A-5zqeA: 22.2	4pm9A-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_A_CEDA301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	ALA A 57 SER A 58 SER A 118 ASN A 120 LYS A 222 GLY A 224 TYR A 231	CES A 301 (-3.5A) CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.2A) None	0.75A	5ghyA-5zqeA: 22.2	5ghyA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_A_CEDA301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	SER A 58 SER A 118 ASN A 120 LYS A 222 GLY A 224 ARG A 257 TYR A 231	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.2A) CES A 301 (-2.9A) None	0.99A	5ghyA-5zqeA: 22.2	5ghyA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_B_CEDB301_1 (BETA-LACTAMASE)	5zqe	- (-)	6 / 12	ALA A 57 SER A 58 ASN A 120 LYS A 222 GLY A 224 TYR A 231	CES A 301 (-3.5A) CES A 301 (-1.3A) CES A 301 (-3.3A) None CES A 301 (-3.2A) None	0.80A	5ghyB-5zqeA: 22.3	5ghyB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_B_CEDB301_1 (BETA-LACTAMASE)	5zqe	- (-)	6 / 12	ALA A 57 SER A 58 SER A 118 ASN A 120 LYS A 222 GLY A 224	CES A 301 (-3.5A) CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.2A)	0.33A	5ghyB-5zqeA: 22.3	5ghyB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_B_CEDB301_1 (BETA-LACTAMASE)	5zqe	- (-)	6 / 12	SER A 58 ASN A 120 LYS A 222 GLY A 224 ARG A 257 TYR A 231	CES A 301 (-1.3A) CES A 301 (-3.3A) None CES A 301 (-3.2A) CES A 301 (-2.9A) None	1.06A	5ghyB-5zqeA: 22.3	5ghyB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_B_CEDB301_1 (BETA-LACTAMASE)	5zqe	- (-)	6 / 12	SER A 58 SER A 118 ASN A 120 LYS A 222 GLY A 224 ARG A 257	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.2A) CES A 301 (-2.9A)	0.86A	5ghyB-5zqeA: 22.3	5ghyB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_A_CEDA301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 11	ALA A 57 SER A 58 SER A 118 ASN A 120 LYS A 222 THR A 223 GLY A 224	CES A 301 (-3.5A) CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A)	0.33A	5ghzA-5zqeA: 22.3	5ghzA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_A_CEDA301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 11	SER A 58 SER A 118 ASN A 120 LYS A 222 THR A 223 GLY A 224 ARG A 257	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A) CES A 301 (-2.9A)	0.84A	5ghzA-5zqeA: 22.3	5ghzA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_B_CEDB301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 10	ALA A 57 SER A 58 SER A 118 ASN A 120 LYS A 222 THR A 223 GLY A 224	CES A 301 (-3.5A) CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A)	0.34A	5ghzB-5zqeA: 22.2	5ghzB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_B_CEDB301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 10	SER A 58 SER A 118 ASN A 120 LYS A 222 THR A 223 GLY A 224 ARG A 257	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-3.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A) CES A 301 (-2.9A)	0.85A	5ghzB-5zqeA: 22.2	5ghzB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JQ7_B_T0RB705_2 (ENVELOPE GLYCOPROTEIN 2)	5zqe	- (-)	4 / 7	LEU A 249 THR A 226 ASP A 161 LEU A 174	None CES A 301 (-4.4A) None None	0.86A	5jq7B-5zqeA: undetectable	5jq7B-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	5zqe	- (-)	8 / 12	SER A 58 SER A 118 THR A 208 ARG A 257 LYS A 222 THR A 223 GLY A 224 ASP A 227	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-4.3A) CES A 301 (-2.9A) None CES A 301 (-3.6A) CES A 301 (-3.2A) None	0.82A	6b5yB-5zqeA: 21.8	6b5yB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	5zqe	- (-)	6 / 12	SER A 58 SER A 118 THR A 208 LYS A 222 THR A 223 GLY A 224	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-4.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A)	0.55A	6b5yD-5zqeA: 21.6	6b5yD-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	5zqe	- (-)	6 / 12	SER A 58 THR A 208 LYS A 222 THR A 223 GLY A 224 ASP A 227	CES A 301 (-1.3A) CES A 301 (-4.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A) None	0.67A	6b5yD-5zqeA: 21.6	6b5yD-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	SER A 58 SER A 118 THR A 208 LYS A 222 THR A 223 GLY A 224 ASP A 227	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-4.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A) None	0.62A	6b68B-5zqeA: 21.7	6b68B-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	SER A 58 SER A 118 THR A 208 ARG A 257 LYS A 222 GLY A 224 ASP A 227	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-4.3A) CES A 301 (-2.9A) None CES A 301 (-3.2A) None	0.81A	6b68D-5zqeA: 21.6	6b68D-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	SER A 58 SER A 118 THR A 208 LYS A 222 THR A 223 GLY A 224 ASP A 227	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-4.3A) None CES A 301 (-3.6A) CES A 301 (-3.2A) None	0.66A	6b69A-5zqeA: 21.7 6b69B-5zqeA: 21.6	6b69A-5zqeA: undetectable 6b69B-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	SER A 58 SER A 118 THR A 208 ARG A 257 LYS A 222 THR A 223 GLY A 224	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-4.3A) CES A 301 (-2.9A) None CES A 301 (-3.6A) CES A 301 (-3.2A)	0.53A	6b69D-5zqeA: 21.6	6b69D-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	5zqe	- (-)	8 / 12	SER A 58 SER A 118 THR A 208 ARG A 257 LYS A 222 THR A 223 GLY A 224 ASP A 227	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-4.3A) CES A 301 (-2.9A) None CES A 301 (-3.6A) CES A 301 (-3.2A) None	0.79A	6b6aB-5zqeA: 21.6	6b6aB-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	SER A 58 SER A 118 ARG A 257 LYS A 222 THR A 223 GLY A 224 ASP A 227	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-2.9A) None CES A 301 (-3.6A) CES A 301 (-3.2A) None	0.84A	6b6aD-5zqeA: 21.7	6b6aD-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	5zqe	- (-)	6 / 12	SER A 58 SER A 118 ARG A 257 LYS A 222 THR A 223 GLY A 224	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-2.9A) None CES A 301 (-3.6A) CES A 301 (-3.2A)	0.66A	6b6cA-5zqeA: 21.8	6b6cA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	5zqe	- (-)	7 / 12	SER A 58 SER A 118 THR A 208 ARG A 257 LYS A 222 THR A 223 GLY A 224	CES A 301 (-1.3A) CES A 301 ( 3.7A) CES A 301 (-4.3A) CES A 301 (-2.9A) None CES A 301 (-3.6A) CES A 301 (-3.2A)	0.63A	6b6eA-5zqeA: 21.8	6b6eA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	5zqe	- (-)	6 / 12	SER A 58 SER A 118 LYS A 222 THR A 223 GLY A 224 ASP A 227	CES A 301 (-1.3A) CES A 301 ( 3.7A) None CES A 301 (-3.6A) CES A 301 (-3.2A) None	0.75A	6b6fA-5zqeA: 21.6	6b6fA-5zqeA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C79_A_CE3A301_1 (BETA-LACTAMASE TOHO-1)	5zqe	- (-)	5 / 12	SER A 118 ASN A 120 THR A 208 LYS A 222 GLY A 224	CES A 301 ( 3.7A) CES A 301 (-3.3A) CES A 301 (-4.3A) None CES A 301 (-3.2A)	0.33A	6c79A-5zqeA: 22.5	6c79A-5zqeA: undetectable

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1GHM_A_CEDA1_1","BETA-LACTAMASE","5zqe","-","-",7,"ALA A  57;SER A  58;LYS A  61;SER A 118;ASN A 120;LYS A 222;GLY A 224","CES A 301 (-3.5A);CES A 301 (-1.3A);CES A 301 ( 4.1A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.2A)","0.37A","1ghmA-5zqeA:21.4",null],["1GHM_A_CEDA1_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;LYS A  61;SER A 118;ASN A 120;LYS A 222;GLY A 224;ARG A 257","CES A 301 (-1.3A);CES A 301 ( 4.1A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.2A);CES A 301 (-2.9A)","0.79A","1ghmA-5zqeA:21.4","1ghmA-5zqeA:undetectable"],["1I2W_A_CFXA1300_1","BETA-LACTAMASE","5zqe","-","-",8,"ALA A  57;SER A  58;LYS A  61;SER A 118;ASN A 120;THR A 208;LYS A 222;GLY A 224","CES A 301 (-3.5A);CES A 301 (-1.3A);CES A 301 ( 4.1A);CES A 301 ( 3.7A);CES A 301 (-3.3A);CES A 301 (-4.3A);None;CES A 301 (-3.2A)","0.44A","1i2wA-5zqeA:22.4","1ghmA-5zqeA:undetectable"],["1I2W_B_CFXB2300_1","BETA-LACTAMASE","5zqe","-","-",7,"ALA A  57;SER A  58;LYS A  61;SER A 118;ASN A 120;THR A 208;GLY A 224","CES A 301 (-3.5A);CES A 301 (-1.3A);CES A 301 ( 4.1A);CES A 301 ( 3.7A);CES A 301 (-3.3A);CES A 301 (-4.3A);CES A 301 (-3.2A)","0.48A","1i2wB-5zqeA:22.3","1i2wA-5zqeA:undetectable"],["1I2W_B_CFXB2300_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;LYS A  61;SER A 118;ASN A 120;THR A 208;GLY A 224;ARG A 257","CES A 301 (-1.3A);CES A 301 ( 4.1A);CES A 301 ( 3.7A);CES A 301 (-3.3A);CES A 301 (-4.3A);CES A 301 (-3.2A);CES A 301 (-2.9A)","0.86A","1i2wB-5zqeA:22.3","1i2wB-5zqeA:undetectable"],["1YMX_A_CFXA1001_1","BETA-LACTAMASE CTX-M-9","5zqe","-","-",8,"SER A  58;LYS A  61;SER A 118;ASN A 120;THR A 208;LYS A 222;GLY A 224;ASP A 227","CES A 301 (-1.3A);CES A 301 ( 4.1A);CES A 301 ( 3.7A);CES A 301 (-3.3A);CES A 301 (-4.3A);None;CES A 301 (-3.2A);None","0.89A","1ymxA-5zqeA:22.1","1i2wB-5zqeA:undetectable"],["1YMX_B_CFXB1002_1","BETA-LACTAMASE CTX-M-9","5zqe","-","-",7,"SER A  58;LYS A  61;SER A 118;ASN A 120;LYS A 222;GLY A 224;ASP A 227","CES A 301 (-1.3A);CES A 301 ( 4.1A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.2A);None","0.81A","1ymxB-5zqeA:22.2","1ymxA-5zqeA:undetectable"],["3HLW_A_CE3A301_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5zqe","-","-",6,"LYS A  61;SER A 118;ASN A 120;THR A 208;LYS A 222;GLY A 224","CES A 301 ( 4.1A);CES A 301 ( 3.7A);CES A 301 (-3.3A);CES A 301 (-4.3A);None;CES A 301 (-3.2A)","0.39A","3hlwA-5zqeA:22.2","1ymxB-5zqeA:undetectable"],["3HLW_B_CE3B302_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5zqe","-","-",6,"SER A 118;ASN A 120;THR A 208;LYS A 222;THR A 223;GLY A 224","CES A 301 ( 3.7A);CES A 301 (-3.3A);CES A 301 (-4.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A)","0.33A","3hlwB-5zqeA:22.2","3hlwA-5zqeA:undetectable"],["3HUO_A_PNNA300_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5zqe","-","-",6,"LYS A  61;ASN A 120;LYS A 222;THR A 223;GLY A 224;ASP A 227","CES A 301 ( 4.1A);CES A 301 (-3.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);None","0.75A","3huoA-5zqeA:22.1","3hlwB-5zqeA:undetectable"],["3HUO_B_PNNB301_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5zqe","-","-",5,"LYS A  61;ASN A 120;LYS A 222;GLY A 224;ASP A 227","CES A 301 ( 4.1A);CES A 301 (-3.3A);None;CES A 301 (-3.2A);None","0.80A","3huoB-5zqeA:22.2","3huoA-5zqeA:undetectable"],["3MZE_A_CFXA364_1","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA","5zqe","-","-",9,"ALA A  57;SER A  58;LYS A  61;ASN A 120;LEU A 160;THR A 223;GLY A 224;THR A 226;ARG A 257","CES A 301 (-3.5A);CES A 301 (-1.3A);CES A 301 ( 4.1A);CES A 301 (-3.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);CES A 301 (-4.4A);CES A 301 (-2.9A)","0.63A","3mzeA-5zqeA:33.7","3huoB-5zqeA:undetectable"],["3NY4_A_SMXA308_1","BETA-LACTAMASE","5zqe","-","-",8,"SER A  58;SER A 118;THR A 208;ARG A 257;LYS A 222;THR A 223;GLY A 224;ASP A 227","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-4.3A);CES A 301 (-2.9A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);None","0.95A","3ny4A-5zqeA:21.5","3mzeA-5zqeA:undetectable"],["3Q07_A_WPPA300_1","BETA-LACTAMASE","5zqe","-","-",6,"LYS A  61;SER A 118;ASN A 120;LYS A 222;GLY A 224;ASP A 227","CES A 301 ( 4.1A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.2A);None","0.68A","3q07A-5zqeA:22.1","3ny4A-5zqeA:undetectable"],["3Q07_B_WPPB400_1","BETA-LACTAMASE","5zqe","-","-",6,"LYS A  61;SER A 118;ASN A 120;LYS A 222;GLY A 224;ASP A 227","CES A 301 ( 4.1A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.2A);None","0.76A","3q07B-5zqeA:9.9","3q07A-5zqeA:undetectable"],["3SH8_A_CEDA1_1","BETA-LACTAMASE","5zqe","-","-",7,"ALA A  57;SER A  58;SER A 118;ASN A 120;LYS A 222;THR A 223;GLY A 224","CES A 301 (-3.5A);CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A)","0.36A","3sh8A-5zqeA:22.7","3q07B-5zqeA:undetectable"],["3SH8_A_CEDA1_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;SER A 118;ASN A 120;LYS A 222;THR A 223;GLY A 224;ARG A 257","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);CES A 301 (-2.9A)","0.85A","3sh8A-5zqeA:22.7","3sh8A-5zqeA:undetectable"],["3SH8_B_CEDB1_1","BETA-LACTAMASE","5zqe","-","-",7,"ALA A  57;SER A  58;LYS A  61;ASN A 120;LYS A 222;GLY A 224;TYR A 231","CES A 301 (-3.5A);CES A 301 (-1.3A);CES A 301 ( 4.1A);CES A 301 (-3.3A);None;CES A 301 (-3.2A);None","0.78A","3sh8B-5zqeA:22.4","3sh8A-5zqeA:undetectable"],["3SH8_B_CEDB1_1","BETA-LACTAMASE","5zqe","-","-",7,"ALA A  57;SER A  58;LYS A  61;SER A 118;ASN A 120;LYS A 222;GLY A 224","CES A 301 (-3.5A);CES A 301 (-1.3A);CES A 301 ( 4.1A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.2A)","0.37A","3sh8B-5zqeA:22.4","3sh8B-5zqeA:undetectable"],["3SH8_B_CEDB1_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;LYS A  61;ASN A 120;LYS A 222;GLY A 224;ARG A 257;TYR A 231","CES A 301 (-1.3A);CES A 301 ( 4.1A);CES A 301 (-3.3A);None;CES A 301 (-3.2A);CES A 301 (-2.9A);None","1.02A","3sh8B-5zqeA:22.4","3sh8B-5zqeA:undetectable"],["3SH8_B_CEDB1_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;LYS A  61;SER A 118;ASN A 120;LYS A 222;GLY A 224;ARG A 257","CES A 301 (-1.3A);CES A 301 ( 4.1A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.2A);CES A 301 (-2.9A)","0.82A","3sh8B-5zqeA:22.4","3sh8B-5zqeA:undetectable"],["4EUZ_A_MEMA401_1","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","5zqe","-","-",7,"LYS A  61;SER A 118;ASN A 120;THR A 208;LYS A 222;THR A 223;GLY A 224","CES A 301 ( 4.1A);CES A 301 ( 3.7A);CES A 301 (-3.3A);CES A 301 (-4.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A)","0.52A","4euzA-5zqeA:22.1","3sh8B-5zqeA:undetectable"],["4EUZ_A_MEMA401_1","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","5zqe","-","-",7,"SER A 118;ASN A 120;LEU A 160;THR A 208;LYS A 222;THR A 223;GLY A 224","CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-4.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A)","0.82A","4euzA-5zqeA:22.1","4euzA-5zqeA:undetectable"],["4FH2_A_0RNA303_1","BETA-LACTAMASE SHV-1","5zqe","-","-",5,"SER A 118;ASN A 120;LYS A 222;THR A 223;GLY A 224","CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A)","0.58A","4fh2A-5zqeA:22.5","4euzA-5zqeA:undetectable"],["4FH2_A_0RNA303_1","BETA-LACTAMASE SHV-1","5zqe","-","-",5,"SER A 118;ASN A 120;THR A 223;GLY A 224;ARG A 257","CES A 301 ( 3.7A);CES A 301 (-3.3A);CES A 301 (-3.6A);CES A 301 (-3.2A);CES A 301 (-2.9A)","1.14A","4fh2A-5zqeA:22.5","4fh2A-5zqeA:undetectable"],["4N9K_A_CEDA301_1","BETA-LACTAMASE","5zqe","-","-",7,"ALA A  57;SER A  58;SER A 118;ASN A 120;LYS A 222;THR A 223;GLY A 224","CES A 301 (-3.5A);CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A)","0.35A","4n9kA-5zqeA:22.5","4fh2A-5zqeA:undetectable"],["4N9K_A_CEDA301_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;SER A 118;ASN A 120;LYS A 222;THR A 223;GLY A 224;ARG A 257","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);CES A 301 (-2.9A)","0.82A","4n9kA-5zqeA:22.5","4n9kA-5zqeA:undetectable"],["4N9K_B_CEDB301_1","BETA-LACTAMASE","5zqe","-","-",7,"ALA A  57;SER A  58;ASN A 120;LYS A 222;THR A 223;GLY A 224;TYR A 231","CES A 301 (-3.5A);CES A 301 (-1.3A);CES A 301 (-3.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);None","0.72A","4n9kB-5zqeA:22.6","4n9kA-5zqeA:undetectable"],["4N9K_B_CEDB301_1","BETA-LACTAMASE","5zqe","-","-",7,"ALA A  57;SER A  58;SER A 118;ASN A 120;LYS A 222;THR A 223;GLY A 224","CES A 301 (-3.5A);CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A)","0.32A","4n9kB-5zqeA:22.6","4n9kB-5zqeA:undetectable"],["4N9K_B_CEDB301_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;ASN A 120;LYS A 222;THR A 223;GLY A 224;ARG A 257;TYR A 231","CES A 301 (-1.3A);CES A 301 (-3.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);CES A 301 (-2.9A);None","1.00A","4n9kB-5zqeA:22.6","4n9kB-5zqeA:undetectable"],["4N9K_B_CEDB301_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;SER A 118;ASN A 120;LYS A 222;THR A 223;GLY A 224;ARG A 257","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);CES A 301 (-2.9A)","0.84A","4n9kB-5zqeA:22.6","4n9kB-5zqeA:undetectable"],["4PM5_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","5zqe","-","-",5,"ASN A 120;THR A 208;LYS A 222;THR A 223;GLY A 224","CES A 301 (-3.3A);CES A 301 (-4.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A)","0.27A","4pm5A-5zqeA:22.1","4n9kB-5zqeA:undetectable"],["4PM7_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","5zqe","-","-",5,"LYS A  61;ASN A 120;THR A 208;LYS A 222;GLY A 224","CES A 301 ( 4.1A);CES A 301 (-3.3A);CES A 301 (-4.3A);None;CES A 301 (-3.2A)","0.38A","4pm7A-5zqeA:22.0","4pm5A-5zqeA:undetectable"],["4PM9_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","5zqe","-","-",5,"ASN A 120;THR A 208;LYS A 222;THR A 223;GLY A 224","CES A 301 (-3.3A);CES A 301 (-4.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A)","0.29A","4pm9A-5zqeA:22.2","4pm7A-5zqeA:undetectable"],["5GHY_A_CEDA301_1","BETA-LACTAMASE","5zqe","-","-",7,"ALA A  57;SER A  58;SER A 118;ASN A 120;LYS A 222;GLY A 224;TYR A 231","CES A 301 (-3.5A);CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.2A);None","0.75A","5ghyA-5zqeA:22.2","4pm9A-5zqeA:undetectable"],["5GHY_A_CEDA301_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;SER A 118;ASN A 120;LYS A 222;GLY A 224;ARG A 257;TYR A 231","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.2A);CES A 301 (-2.9A);None","0.99A","5ghyA-5zqeA:22.2","5ghyA-5zqeA:undetectable"],["5GHY_B_CEDB301_1","BETA-LACTAMASE","5zqe","-","-",6,"ALA A  57;SER A  58;ASN A 120;LYS A 222;GLY A 224;TYR A 231","CES A 301 (-3.5A);CES A 301 (-1.3A);CES A 301 (-3.3A);None;CES A 301 (-3.2A);None","0.80A","5ghyB-5zqeA:22.3","5ghyA-5zqeA:undetectable"],["5GHY_B_CEDB301_1","BETA-LACTAMASE","5zqe","-","-",6,"ALA A  57;SER A  58;SER A 118;ASN A 120;LYS A 222;GLY A 224","CES A 301 (-3.5A);CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.2A)","0.33A","5ghyB-5zqeA:22.3","5ghyB-5zqeA:undetectable"],["5GHY_B_CEDB301_1","BETA-LACTAMASE","5zqe","-","-",6,"SER A  58;ASN A 120;LYS A 222;GLY A 224;ARG A 257;TYR A 231","CES A 301 (-1.3A);CES A 301 (-3.3A);None;CES A 301 (-3.2A);CES A 301 (-2.9A);None","1.06A","5ghyB-5zqeA:22.3","5ghyB-5zqeA:undetectable"],["5GHY_B_CEDB301_1","BETA-LACTAMASE","5zqe","-","-",6,"SER A  58;SER A 118;ASN A 120;LYS A 222;GLY A 224;ARG A 257","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.2A);CES A 301 (-2.9A)","0.86A","5ghyB-5zqeA:22.3","5ghyB-5zqeA:undetectable"],["5GHZ_A_CEDA301_1","BETA-LACTAMASE","5zqe","-","-",7,"ALA A  57;SER A  58;SER A 118;ASN A 120;LYS A 222;THR A 223;GLY A 224","CES A 301 (-3.5A);CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A)","0.33A","5ghzA-5zqeA:22.3","5ghyB-5zqeA:undetectable"],["5GHZ_A_CEDA301_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;SER A 118;ASN A 120;LYS A 222;THR A 223;GLY A 224;ARG A 257","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);CES A 301 (-2.9A)","0.84A","5ghzA-5zqeA:22.3","5ghzA-5zqeA:undetectable"],["5GHZ_B_CEDB301_1","BETA-LACTAMASE","5zqe","-","-",7,"ALA A  57;SER A  58;SER A 118;ASN A 120;LYS A 222;THR A 223;GLY A 224","CES A 301 (-3.5A);CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A)","0.34A","5ghzB-5zqeA:22.2","5ghzA-5zqeA:undetectable"],["5GHZ_B_CEDB301_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;SER A 118;ASN A 120;LYS A 222;THR A 223;GLY A 224;ARG A 257","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-3.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);CES A 301 (-2.9A)","0.85A","5ghzB-5zqeA:22.2","5ghzB-5zqeA:undetectable"],["5JQ7_B_T0RB705_2","ENVELOPE GLYCOPROTEIN 2","5zqe","-","-",4,"LEU A 249;THR A 226;ASP A 161;LEU A 174","None;CES A 301 (-4.4A);None;None","0.86A","5jq7B-5zqeA:undetectable","5ghzB-5zqeA:undetectable"],["6B5Y_B_9F2B400_1","BETA-LACTAMASE","5zqe","-","-",8,"SER A  58;SER A 118;THR A 208;ARG A 257;LYS A 222;THR A 223;GLY A 224;ASP A 227","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-4.3A);CES A 301 (-2.9A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);None","0.82A","6b5yB-5zqeA:21.8","5jq7B-5zqeA:undetectable"],["6B5Y_D_9F2D400_1","BETA-LACTAMASE","5zqe","-","-",6,"SER A  58;SER A 118;THR A 208;LYS A 222;THR A 223;GLY A 224","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-4.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A)","0.55A","6b5yD-5zqeA:21.6","6b5yB-5zqeA:undetectable"],["6B5Y_D_9F2D400_1","BETA-LACTAMASE","5zqe","-","-",6,"SER A  58;THR A 208;LYS A 222;THR A 223;GLY A 224;ASP A 227","CES A 301 (-1.3A);CES A 301 (-4.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);None","0.67A","6b5yD-5zqeA:21.6","6b5yD-5zqeA:undetectable"],["6B68_B_9F2B301_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;SER A 118;THR A 208;LYS A 222;THR A 223;GLY A 224;ASP A 227","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-4.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);None","0.62A","6b68B-5zqeA:21.7","6b5yD-5zqeA:undetectable"],["6B68_D_9F2D400_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;SER A 118;THR A 208;ARG A 257;LYS A 222;GLY A 224;ASP A 227","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-4.3A);CES A 301 (-2.9A);None;CES A 301 (-3.2A);None","0.81A","6b68D-5zqeA:21.6","6b68B-5zqeA:undetectable"],["6B69_B_9F2B301_1","BETA-LACTAMASE;BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;SER A 118;THR A 208;LYS A 222;THR A 223;GLY A 224;ASP A 227","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-4.3A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);None","0.66A","6b69A-5zqeA:21.7;6b69B-5zqeA:21.6","6b68D-5zqeA:undetectable"],["6B69_D_9F2D301_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;SER A 118;THR A 208;ARG A 257;LYS A 222;THR A 223;GLY A 224","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-4.3A);CES A 301 (-2.9A);None;CES A 301 (-3.6A);CES A 301 (-3.2A)","0.53A","6b69D-5zqeA:21.6","6b69A-5zqeA:undetectable;6b69B-5zqeA:undetectable"],["6B6A_B_9F2B301_1","BETA-LACTAMASE","5zqe","-","-",8,"SER A  58;SER A 118;THR A 208;ARG A 257;LYS A 222;THR A 223;GLY A 224;ASP A 227","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-4.3A);CES A 301 (-2.9A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);None","0.79A","6b6aB-5zqeA:21.6","6b69D-5zqeA:undetectable"],["6B6A_D_9F2D301_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;SER A 118;ARG A 257;LYS A 222;THR A 223;GLY A 224;ASP A 227","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-2.9A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);None","0.84A","6b6aD-5zqeA:21.7","6b6aB-5zqeA:undetectable"],["6B6C_A_9F2A301_1","BETA-LACTAMASE","5zqe","-","-",6,"SER A  58;SER A 118;ARG A 257;LYS A 222;THR A 223;GLY A 224","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-2.9A);None;CES A 301 (-3.6A);CES A 301 (-3.2A)","0.66A","6b6cA-5zqeA:21.8","6b6aD-5zqeA:undetectable"],["6B6E_A_9F2A302_1","BETA-LACTAMASE","5zqe","-","-",7,"SER A  58;SER A 118;THR A 208;ARG A 257;LYS A 222;THR A 223;GLY A 224","CES A 301 (-1.3A);CES A 301 ( 3.7A);CES A 301 (-4.3A);CES A 301 (-2.9A);None;CES A 301 (-3.6A);CES A 301 (-3.2A)","0.63A","6b6eA-5zqeA:21.8","6b6cA-5zqeA:undetectable"],["6B6F_A_9F2A301_1","BETA-LACTAMASE","5zqe","-","-",6,"SER A  58;SER A 118;LYS A 222;THR A 223;GLY A 224;ASP A 227","CES A 301 (-1.3A);CES A 301 ( 3.7A);None;CES A 301 (-3.6A);CES A 301 (-3.2A);None","0.75A","6b6fA-5zqeA:21.6","6b6eA-5zqeA:undetectable"],["6C79_A_CE3A301_1","BETA-LACTAMASE TOHO-1","5zqe","-","-",5,"SER A 118;ASN A 120;THR A 208;LYS A 222;GLY A 224","CES A 301 ( 3.7A);CES A 301 (-3.3A);CES A 301 (-4.3A);None;CES A 301 (-3.2A)","0.33A","6c79A-5zqeA:22.5","6b6fA-5zqeA:undetectable"]]